Sanofi's Drug Dupixent Succeeds in a Late-stage Trial for Chronic Obstructive Pulmonary ... - Latest Tweet by Bloomberg

Sanofi’s drug Dupixent succeeds in a late-stage trial for chronic obstructive pulmonary disease, raising the odds that the blockbuster will be the first biologic medicine cleared to treat the lung disorder https://t.co/idqghQh02E— Bloomberg (@business) March 23, 2023

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)